Home News Concentration of PrEP drug lower in pregnant girls and young women back to News
minute read
Levels of tenofovir-diphosphate, or TFV-DP, in dried blood spots were 31% to 37% lower among African pregnant adolescent girls and young women taking pre-exposure prophylaxis, or PrEP, compared with those who were postpartum, according to study findings from the IMPAACT 2009 trial presented during CROI.
Topics: Press Coverage
12850 East Montview Boulevard
Aurora, CO 80045
303-724-2882
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.
